Health AI Central
Share:
Peer-Reviewed Publication
Eur J Radiol Open2026;16100765.June 1, 2026Journal Article

Evaluation of an artificial intelligence generated Brock score to determine malignancy risk of screen-detected pulmonary nodules.

Kathryn J Long1, Michael Balassone2, Saigopal Sathyamurthy3, Vikash Challa3, Deepak Adarsh3, Gerard A Silvestri2
1Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, United States.
2Medical University of South Carolina, 96 Jonathan Lucas St, Charleston, SC 29425, United States.
3Qure.ai Technologies, Mumbai, India.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Estimation of malignancy risk is a crucial step in the evaluation of indeterminate pulmonary nodules (IPN) on computed tomography (CT) scans. Artificial intelligence (AI) tools can improve the risk prediction of IPN. The purpose of this study was to compare the performance of an AI generated Brock score with standard Brock score to estimate malignancy risk. METHODS: The AI tool qCT (Q…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.